Our SDG Commitment

At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our U.N. SDG 2020 Commitment complements our Health for Humanity 2020 Goals, which focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.

The Johnson & Johnson SDG Commitment

Johnson & Johnson was one of the first major companies to make a public commitment to the SDGs in 2016. Our SDG Commitment extends and significantly builds upon our previous U.N. Millennium Development Goals (MDG) Commitment in 2010 that improved the lives of more than 400 million women and children over the five-year time frame and furthers our long legacy of work in public health around the world.

Our commitment to dedicate our expertise, ideas and ingenuity to catalyze efforts toward achieving SDG 3 (Good Health and Well-being) SDG 5 (Gender Equality) and SDG 17 (Partnership for the Goals) reflects the Company’s unique constellation of strengths.

Our Five Focus Areas

The Johnson & Johnson SDG commitment focuses on five areas in which the Company is uniquely positioned to create sustainable and scalable impact:

Health Workforce

ON NOW

Women's and Children's Health

ON NOW

Essential Surgery

ON NOW

Global Disease Challenges

ON NOW

Environmental Health

ON NOW

Accelerating Progress Towards Our SDG Goals

Putting Kids Around the Globe First: Johnson & Johnson Announces a $10 Million Pledge to UNICEF

ON NOW

The Changing Face of Last Mile Health

ON NOW

Sharing knowledge and resources to train the health workforce of the future

ON NOW

Nurses learn neonatal resuscitation techniques in Uganda

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

ON NOW

Dr. Paul Stoffels, Johnson & Johnson Chief Scientific Officer, at 2017 Global Citizen Festival

6 Entrepreneurs Whose Innovations Could Make GenH the Healthiest Yet

ON NOW

Johnson & Johnson Consumer Inc. Makes a New Pledge to Help Tackle Plastic Waste

ON NOW

More From Johnson & Johnson

Latest News

8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine

As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.

ON NOW

Innovation

From Lab to Vaccine Vial: The Historic Manufacturing Journey of Johnson & Johnson's Janssen COVID-19 Vaccine

As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production, we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.

ON NOW

Innovation

One Year Later: The Head of Johnson & Johnson China Looks Back on What We've Learned From the Pandemic—and How It Can Help Shape the Future

The Head of Johnson & Johnson China Looks Back on What We've Learned From the Pandemic—and How It Can Help Shape the Future

Will Song's teams were on the front lines when COVID-19 shut down the city of Wuhan. One year to the day that the World Health Organization declared the disease a pandemic, he shares how the company kept going during the crisis and the innovative ideas that emerged from it.

ON NOW